ストックスクリーナーアプリを入手
12.85
0.31%
-0.04
前日終値:
$12.89
開ける：
$12.94
24時間の取引高:
54,697
Relative Volume:
0.56
時価総額：
$340.83M
収益：
$50.14M
当期純損益:
$-35.38M
株価収益率:
-10.53
EPS:
-1.22
ネットキャッシュフロー:
$-39.46M
1週間 パフォーマンス:
-1.53%
1か月 パフォーマンス:
+26.85%
6か月 パフォーマンス:
+58.64%
1年 パフォーマンス:
+18.43%
1日の値動き範囲:
$12.63
$13.04
1週間の範囲:
$12.58
$13.70
52週間の値動き範囲:
$7.51
$18.93
Avita Medical Inc Stock (RCEL) Company Profile
RCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
12.85 | 340.83M | 50.14M | -35.38M | -39.46M | -1.22 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
AVITA Medical's SWOT analysis: regenerative medicine firm's stock faces growth hurdles - Investing.com
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference - The Manila Times
AVITA Medical to Present at Piper Sandler Healthcare Conference in December | RCEL Stock News - StockTitan
Trend Tracker for (RCEL) - Stock Traders Daily
AVITA Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AVHHL (AVITA Medical) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
AVHHL (AVITA Medical) Enterprise Value : $341.00 Mil (As of Nov. 20, 2024) - GuruFocus.com
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand - The Manila Times
AVITA Medical Expands RECELL Platform to Australia, NZ in Strategic Distribution Deal | RCEL Stock News - StockTitan
AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2024 Earnings Call Transcript - Insider Monkey
AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
RCELAvita Medical, Inc. Latest Stock News & Market Updates - StockTitan
AVITA Medical's (RCEL) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical Inc (AVHHL) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses By GuruFocus - Investing.com Canada
AVITA Medical Inc (AVHHL) Q3 2024 Earnings Call Highlights: Reve - GuruFocus.com
RECELL boosts revenue, but AVITA feels the burn - ShareCafe
Avita Medical earnings missed by $0.19, revenue topped estimates - Investing.com UK
AVITA Medical Reports Third Quarter Financial Results - The Manila Times
AVITA Medical Revenue Surges 44% to $19.5M, Despite Widening Losses | Q3 Earnings | RCEL Stock News - StockTitan
AVITA Medical (ASX:AVH) Total Inventories : A$10.10 Mil (As of Jun. 2024) - GuruFocus.com
When (RCEL) Moves Investors should Listen - Stock Traders Daily
AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday - Defense World
AVITA Medical (RCEL) Set to Announce Quarterly Earnings on Thursday - MarketBeat
AVHHL (AVITA Medical) Net Income From Continuing Operations : $-49.83 Mil (TTM As of Jun. 2024) - GuruFocus.com
How the (RCEL) price action is used to our Advantage - Stock Traders Daily
The Manufacturers Life Insurance Company Invests $86,000 in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AQR Capital Management LLC Sells 67,535 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
Financial Analysis: AVITA Medical (NASDAQ:RCEL) & KORU Medical Systems (NASDAQ:KRMD) - Defense World
Essex Investment Management Co. LLC Invests $2.48 Million in AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat
(RCEL) Long Term Investment Analysis - Stock Traders Daily
AVITA Medical to Announce Third Quarter 2024 Financial Results - The Manila Times
AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago - Yahoo Finance
These small cap ASX shares could rise 25% to 100% - The Motley Fool Australia
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - Simply Wall St
AVITA Medical Inc (RCEL) Trading 4.08% Higher on Oct 2 - GuruFocus.com
AVITA Medical Headed For Its Most Important Report, I'm Extremely Bullish - Seeking Alpha
AVITA Medical's SWOT analysis: regenerative medicine firm faces growth hurdles - Investing.com India
AVITA Medical (FRA:51KA) Revenue per Share : €1.96 (TTM As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KA) Dividend Payout Ratio : 0.00 (As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KA) Inventories, Raw Materials & Compo - GuruFocus.com
AVITA Medical, Inc. (NASDAQ:RCEL) Holdings Lowered by Bank of New York Mellon Corp - Defense World
AVITA Medical (FRA:51KA) Total Assets : €81.59 Mil (As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KB) Free Cash Flow : €-53.82 Mil (TTM As of Jun. 2024) - GuruFocus.com
AVITA Medical (FRA:51KA) Momentum Rank : 4 (As of Sep. 29, 2024) - GuruFocus.com
AVITA Medical Inc (ASX:AVH) Q2 2024 Earnings Call Transcript Hig - GuruFocus.com
Top High Growth Tech Stocks To Watch In September 2024 - Simply Wall St
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference - StockTitan
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
Avita Medical Inc (RCEL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Feb 28 '24 |
Buy |
17.39 |
1,250 |
21,738 |
18,734 |
| CORBETT JAMES | CEO |
Dec 26 '23 |
Sale |
13.29 |
1,445 |
19,204 |
11,580 |
| COOK JEREMY CURNOCK | Director |
Dec 13 '23 |
Sale |
12.27 |
2,518 |
30,896 |
20,596 |
| O'Toole David D | CFO |
Dec 12 '23 |
Buy |
12.45 |
950 |
11,828 |
17,484 |
| O'Toole David D | CFO |
Dec 01 '23 |
Buy |
10.68 |
500 |
5,340 |
16,534 |
0.65%
大文字化:
|
ボリューム (24 時間):